Determinants of serum total and free testosterone levels in women over the age of 65 years

被引:55
作者
Cappola, Anne R.
Ratcliffe, Sarah J.
Bhasin, Shalender
Blackman, Marc R.
Cauley, Jane
Robbins, John
Zmuda, Joseph M.
Harris, Tamara
Fried, Linda P.
机构
[1] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA
[2] Boston Univ, Endocrinol Sect, Boston, MA 02118 USA
[3] NIA, Endocrine Sect, Lab Clin Invest, Natl Ctr Complementary & Alternat Med,NIH, Bethesda, MD 20892 USA
[4] NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA
[5] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA
[6] Univ Calif Davis, Div Gen Internal Med, Sacramento, CA 95817 USA
[7] Johns Hopkins Med Inst, Div Geriatr Med & Gerontol, Baltimore, MD 21205 USA
[8] Johns Hopkins Med Inst, Ctr Aging & Hlth, Baltimore, MD 21205 USA
关键词
D O I
10.1210/jc.2006-1399
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Little is known about testosterone ( T) levels and their determinants in women of late postmenopausal age. Objective: We describe levels of total and free T and selected factors that influence these levels in a random sample of older women. Design: Levels of serum total T and free T by microdialysis were measured using ultrasensitive assays in 347 community-dwelling women aged 65-98 yr enrolled in the Cardiovascular Health Study. Cross-sectional analyses were performed to define factors associated with total and free T levels. Results: In adjusted models: 1) total T levels declined with age until 80, whereas free T levels did not vary by age; 2) women with bilateral oophorectomy had 23% lower total T and 16% lower free T levels than those with at least one intact ovary; 3) oral estrogen users had total and free T levels that were 47% lower than never users; 4) obese women had 47% higher total T and 20% higher free T levels, and overweight women had 24% higher total T and 14% higher free T levels, than normal weight women; and 5) free T levels were 51% higher in black women. Corticosteroid users had 75% lower total T and 43% lower free T levels than nonusers. Conclusions: Bilateral oophorectomy, estrogen use, corticosteroid use, and low body mass index are independent risk factors for lower T levels in women aged 65 yr and over. Although highly prevalent in women of this age, the physiological significance of low T levels in late postmenopausal women requires further investigation.
引用
收藏
页码:509 / 516
页数:8
相关论文
共 45 条
  • [1] REACTION OF METHANESULFONYL NITRENE WITH BENZENE - ATTEMPTS TO GENERATE SULFONYL NITRENES FROM SOURCES OTHER THAN AZIDES
    ABRAMOVITCH, RA
    BAILEY, TD
    TAKAYA, T
    UMA, V
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1974, 39 (03) : 340 - 345
  • [2] ADASHI EY, 1994, FERTIL STERIL, V62, P20
  • [3] Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial
    Anderson, GL
    Limacher, M
    Assaf, AR
    Bassford, T
    Beresford, SAA
    Black, H
    Bonds, D
    Brunner, R
    Brzyski, R
    Caan, B
    Chlebowski, R
    Curb, D
    Gass, M
    Hays, J
    Heiss, G
    Hendrix, S
    Howard, BV
    Hsia, J
    Hubbell, A
    Jackson, R
    Johnson, KC
    Judd, H
    Kotchen, JM
    Kuller, L
    LaCroix, AZ
    Lane, D
    Langer, RD
    Lasser, N
    Lewis, CE
    Manson, J
    Margolis, K
    Ockene, J
    O'Sullivan, MJ
    Phillips, L
    Prentice, RL
    Ritenbaugh, C
    Robbins, J
    Rossouw, JE
    Sarto, G
    Stefanick, ML
    Van Horn, L
    Wactawski-Wende, J
    Wallace, R
    Wassertheil-Smoller, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14): : 1701 - 1712
  • [4] The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society
    不详
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (05): : 497 - 511
  • [5] Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment
    Bachmann, G
    Bancroft, J
    Braunstein, G
    Burger, H
    Davis, S
    Dennerstein, L
    Goldstein, I
    Guay, A
    Leiblum, S
    Lobo, R
    Notelovitz, M
    Rosen, R
    Sarrel, P
    Sherwin, B
    Simon, J
    Simpson, E
    Shifren, J
    Spark, R
    Traish, A
    [J]. FERTILITY AND STERILITY, 2002, 77 (04) : 660 - 665
  • [6] Editorial: Female androgen deficiency syndrome - An unproven hypothesis
    Bhasin, S
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (08) : 4970 - 4972
  • [7] Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women - A randomized, placebo-controlled trial
    Braunstein, GD
    Sundwall, DA
    Katz, M
    Shifren, JL
    Buster, JE
    Simon, JA
    Bachman, G
    Aguirre, OA
    Lucas, JD
    Rodenberg, C
    Buch, A
    Watts, NB
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (14) : 1582 - 1589
  • [8] A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition
    Burger, HG
    Dudley, EC
    Cui, JS
    Dennerstein, L
    Hopper, JL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (08) : 2832 - 2838
  • [9] Testosterone patch for low sexual desire in surgically menopausal women: A randomized trial
    Buster, JE
    Kingsberg, SA
    Aguirre, O
    Brovm, C
    Breaux, JG
    Buch, A
    Rodenberg, CA
    Wekselman, K
    Casson, P
    [J]. OBSTETRICS AND GYNECOLOGY, 2005, 105 (05) : 944 - 952
  • [10] Effect of postmenopausal estrogen replacement on circulating androgens
    Casson, PR
    ElkindHirsch, KE
    Buster, JE
    Hornsby, PJ
    Carson, SA
    Snabes, MC
    [J]. OBSTETRICS AND GYNECOLOGY, 1997, 90 (06) : 995 - 998